Bile acids are physiologically important metabolites, which are synthesized in liver as the end products of cholesterol metabolism and then secreted into intestine. They are amphiphilic molecules which play a critical role in the digestion and absorption of fats and fat-soluble vitamins through emulsification. The concentration of bile acids is an indicator for liver function. Individual suffering from liver diseases has a sharp increase in bile acid concentrations. Hence, the concentration level of bile acids has long been used as a biomarker for the early diagnosis of intestinal and liver diseases. Conventional methods of bile acid detection such as chromatography-mass spectrometry and enzymatic reactions are complex and expensive. It is highly desired to have a simple, fast, and low-cost detection of bile acids that is available for self-testing or point-of-care testing. To achieve this goal, we develop a liquid crystal-based biosensor for the detection of bile acids. The sensor platform is based on the anchoring transition of liquid crystals (LCs) at the sodium dodecyl sulfate (SDS)-laden LC/aqueous interface for the detection of bile acids in aqueous solution. The first part of this dissertation focuses on the detection mechanism of bile acids. Our studies show that the displacement of SDS from the LC/aqueous interface by the competitive adsorption of bile acids induces a homeotropic-to-planar anchoring transition of the LC at the interface, providing an optical signature for the simple and rapid detection of bile acids. The adsorption of bile acids on the interface was found to follow Langmuir-Freundlich isotherm. The adsorption kinetics of different bile acids is compared. We find that both the number and position of hydroxyl groups of bile acids affect their adsorption kinetics. The different optical patterns of LC films formed by the adsorption of bile acids are also discussed. The second part of this dissertation studies the effect of solution conditions, surfactants, and liquid crystals on the detection limit of the LC-based biosensor for bile acids. Low pH and high ionic strength in the aqueous solution can reduce the electrostatic interaction between SDS and bile acids, which leads to a decreased detection limit. Surfactants with smaller headgroup and lower packing density also help to reduce the detection limit. To further reduce the detection limit, we investigate the effect of LC structures and find that LCs with a shorter chain length give lower detection limits. Also, by substituting a phenyl ring with a cyclohexane ring, we find that the detection limit is further reduced due to the decrease of the interaction between the phenyl rings of LCs. By mixing different LCs together, the detection limit can be linearly tuned from 160 μM to 1.5 μM, which is comparable to the traditional methods. But the LC-based biosensors have much simpler design and manufacture process. The third part of this dissertation is to apply this LC-based biosensor to the detection of urinary bile acids. We test the influence of several potential interfering species such as urea, creatinine, uric acid and ascorbic acid by conducting experiments in synthetic urine. By adjusting the concentration of SDS, we are able to eliminate the impact of those interfering species, and demonstrate that the LC-based biosensors can selectively detect urinary bile acids in human urine, suggesting its potential for screening liver dysfunctions. The final part of this dissertation is to investigate the application of LC-based biosensors in detecting the lipolysis process by porcine pancreatic lipase (PPL). It has been a long-standing argument over the role of bile salts on the activity of PPL. Thus, we study the time course of the hydrolysis of phospholipid L-dipalmitoylphosphatidylcholine (L-DPPC) by PPL at LC/aqueous interface. The hydrolysis of L-DPPC leads to a homeotropic-to-tilted anchoring transition of the LC at the interface, which allows the hydrolysis process to be monitored by a polarizing optical microscope. The microscopy image analysis reveals a lag-burst kinetics where a lag phase is followed by a burst phase. The effect of bile acids on these two phases is studied. We find that the activity of PPL both in the presence and absence of colipase can be improved by increasing the concentration of bile acids. The improvement becomes more distinct in the presence of colipase.

The self-assembly of chiral amphiphilic molecules in aqueous solutions is of particular interest because the chirality of individual molecules is often expressed in their supermolecular structures. Self-assembled tubes made of chiral amphiphilic molecules represent useful supramolecular architectures which hold promise as controlled release vehicles for drug delivery, encapsulates for functional molecules, and nanoreactors for chemical reactions. Lithocholic acid (LCA) is a secondary bile acid with the concentration being identical to that of cholesterol in the hepatic bile and gallbladder. It has a rigid, nearly planar hydrophobic steroid nucleus, with four hydrogen atoms and one hydroxyl group directed toward the concave side, and the convex side with three methyl groups. The ionic head with a carboxyl group is linked to the steroid nucleus through a short alkyl chain. In this thesis work, I study the self-assembly behavior of LCA at the liquid-solid interface, in confined spaces, and bulk solution. We find that the initially formed LCA vesicles further assemble into fractal tubes on glass slides by diffusion-limited aggregation and pronglike tubes by the capillary flow generated in an evaporating vesicle solution confined by two parallel glass slides. While in bulk solution, the LCA vesicles linearly aggregate and fuse into spiral tubes at pH 12.0. The spiral tubes can transition into a straight shape as the pH of solution is reduced to 7.4. The shape transition of the tubes is reversible as the pH of solution is adjusted back to 12.0. The pH-switchable shape transition suggests that the self-assembled LCA tubes can act as a supramolecular chemical spring. Finally, the LCA tubes are endowed with optical functionality by embedding cadmium sulfide nanopaticles (CdS) in the tube walls by the co-assembling synthesis of cadmium sulfide iv (CdS) nanoparticles with lithocholic acid (LCA) molecules. The fluorescent composite tubes can undergo pH switchable spiral/straight, which are a promising system for a variety of materials and biological applications.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第24198号 / 医博第4892号 / 新制||医||1060(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 川口 義弥, 教授 松田 秀一, 教授 小濱 和貴 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

A análise das proteínas transportadoras de compostos biliares, antes restrita à fisiologia e à fisiopatologia de colestases, recentemente passou a incluir neoplasias hepato-biliares. O presente estudo teve como objetivo caracterizar a expressão das proteínas ABC de transporte biliar BSEP, MDR3, MRP2 e MRP3 em amostras retrospectivamente colecionadas de 80 casos de autópsias de carcinoma hepatocelular (CHC) e 56 casos de ressecção cirúrgica de colangiocarcinoma (CC). Áreas representativas das neoplasias foram organizadas em tissue microarrays e submetidas à pesquisa imuno-histoquímica (IHQ) com o anticorpo policlonal anti-BSEP (HPA019035) e os anticorpos monoclonais anti-BSEP (F6), anti-MDR3 (P3 II-26), anti-MRP2 (M2 III-6) e anti-MRP3 (DTX-1) com amplificação de sinal mediante uso de sistema de polímeros curtos conjugados à peroxidase. A comparação entre a positividade das reações imuno-histoquímicas para cada anticorpo e as variáveis anatomopatológicas foi realizada através dos testes de qui-quadrado de Pearson ou Exato de Fisher. A positividade das reações IHQ cujos anticorpos propiciaram melhor distinção do sinal positivo vs coloração inespecífica de fundo e detecção de casos positivos e/ou melhor capacidade de discriminar as duas neoplasias hepáticas foi comparada com a positividade observada para as reações IHQ com os anticorpos anti-CEA policlonal, anti-Hep-par-1 e anti-Arginase-1. A expressão canalicular de BSEP nos CHC foi observada em 77,3% (58/75) com o anticorpo monoclonal e 75,9% (60/79) com o anticorpo policlonal. Não foi detectada associação significativa da expressão de BSEP em relação ao tamanho, número dos nódulos e grau de diferenciação de CHC, tendo apenas sido significativamente reduzida (P < 0,05) tal reação nos casos de padrão arquitetural mais complexo. A reatividade dos CHC para o anticorpo monoclonal anti-BSEP foi aparentemente menor que a obtida com a expressão canalicular de CEA, Hep-par-1 e Arginase-1 no CHC, mas esses valores não atingiram significância estatística. Todos os casos de colangiocarcinoma foram negativos para reações IHQ para pesquisa de BSEP, resultado significativamente diferente (P=0,0001) do obtido com uso do Ac policlonal anti-CEA (padrão circunferencial) e Hep-par-1, não tendo sido demonstrada diferença significativa (P=0,222) da expressão de BSEP e de Arginase-1. A expressão canalicular de MDR3 foi observada em 56,4% (44/78) dos casos de CHC, não tendo sido detectada associação significativa quanto ao tamanho e número de nódulos. Foi observada expressão significativamente menor de MDR3 nos casos de CHC de padrão mais complexo (P=0,009), e nos casos de maior grau histológico (P=0,005). A expressão de MDR3 em CHC foi significativamente menor que a de CEA, Hep-par-1 e Arginase-1 (P < 0,05). Todos os casos de colangiocarcinoma foram negativos para a avaliação da expressão de MDR3, diferindo significativamente em relação a expressão de CEA (P=0,001), mas não em comparação a Hep-par-1 e Arginase-1 (P > 0,05). As reações IHQ para detecção de MRP2 exibiram positividade canalicular em 92,3% dos casos de CHC e em 96,3% nos casos de CC. A detecção da alta expressão de MRP2 no CHC foi constante (P > 0,05) em comparação ao tamanho, número dos nódulos, padrão arquitetural e grau histológico de diferenciação de CHC assim como, também não apresentou associação (P > 0,05) com a localização, padrão de crescimento e grau de diferenciação do CC. A reação IHQ para MRP3 resultou positiva em 15/80 casos de CH (18,8%). A reatividade IHQ para MRP foi detectada em 24/54 (44,5%) de CC. Diferente dos transportadores descritos acima, a expressão de MRP3 foi preferencialmente basolateral. A positividade para MRP3 não variou (P > 0,05) em relação ao número, tamanho dos nódulos, padrão arquitetural (inclusive os sólidos), e grau de diferenciação (inclusive os menos diferenciados). A proteína MRP3 esteve expressa regularmente (P > 0,05) em todos os casos de CC, apresentando-se reduzida apenas no subtipo histológico ductular (P=0,023). Em conclusão, o excelente contraste de reação, a frequência razoavelmente alta de positividade de CHC e a plena negatividade de CC para BSEP levam-nos a recomendar a introdução do anticorpo monoclonal anti-BSEP no painel adotado para o diagnóstico diferencial dessas duas neoplasias. A alta expressão de MRP2 no CHC e no CC é conservada independentemente dos parâmetros anatomopatológicos avaliados. A expressão do transportador MRP3 mostrou variação dentre os subtipos histológicos de CC, aspecto que torna promissoras pesquisas futuras para avaliação mais detalhada da expressão deste marcador nos colangiocarcinomas / The assessment of biliary transporters, previously restricted to the physiology and pathophysiology of cholestasis, has recently included hepato-biliary neoplasms. The present study aimed to characterize the expression of BSEP, MDR3, MRP2 and MRP3 biliary transport proteins in retrospectively collected samples from 80 cases of autopsy of hepatocellular carcinoma (HCC) and 56 cases of surgical resection of cholangiocarcinoma (CC). Representative areas of the neoplasms were organized into tissue microarrays and submitted to immunohistochemical (IHC) reaction with polyclonal antibody anti-BSEP (HPA019035) and monoclonal antibodies anti-BSEP (F6), MDR3 (P3 II-26), MRP2 (M2 III-6) and MRP3 (DTX-1). Signal amplification was achieved with a short polymer system conjugated to peroxidase. The comparison between the positivity of the immunohistochemical reactions for each antibody and the pathological variables was performed using the Pearson chi-square test or the Fisher\'s exact test. The performance of antibodies which provided a better distinction of the positive signal vs nonspecific background staining and yield better discrimination between the two hepatic neoplasms was compared with that achieved with the already accepted HCC markers polyclonal anti-CEA, Hep-par-1 and Arginase-1. The canalicular expression of BSEP in HCC was observed in 77.3% (58/75) with the monoclonal antibody and 75.9% (60/79) with the polyclonal antibody. BSEP expression levels were not significantly different according to tumor size, number of nodules and degree of differentiation. The frequency of positive reaction of HCC cases with the monoclonal anti-BSEP was apparently lower than that achieved with the canalicular expression of CEA, Hep-par-1 and Arginase-1, but these values did not reach statistical significance. All cases of cholangiocarcinoma were negative for IHC reactions to BSEP, which was significantly different (P=0.0001) from the results obtained with polyclonal anti-CEA (circumferential pattern) and Hep-par-1, but not from the resultas achieved with Arginase-1 (P=0.222). The canalicular expression of MDR3 was observed in 56.4% (44/78) of HCC cases. Among histological variables, only the finding of more complex architecture (P=0.009) and higher histological grade (P=0.005) of HCC yielded, significantly lower expression of MDR3. The expression of MDR3 in HCC was significantly lower than that of CEA, Hep-par-1 and Arginase-1 (P < 0.05). All cases of cholangiocarcinoma were negative for the evaluation of MDR3 expression, differing significantly with that achieved with polyclonal anti-CEA (P=0.001) but not with that achieved with Hep-par-1 or with Arginase-1 (P > 0.05). The IHC reactions with the MRP2 antibody exhibited canalicular positivity in 92.3% of HCC cases and 96.3% in CC cases. High expression of MRP2 in HCC was constant (P > 0.05) despite changes in size, number of nodules, architectural pattern and histological degree of HCC differentiation, as well as no association (P > 0.05) with the location, pattern of growth and degree of differentiation of CC. The IHC reaction for MRP3 was positive in 15/80 cases of HCC (18.8%) and in 24/54 (44.5%) of CC. Unlike the carriers described above, the hepatocellular expression of MRP3 was preferentially basolateral. Positivity for MRP3 did not vary (P > 0.05) in relation to number, nodule size, architectural standard (including solids), and degree of differentiation. The MRP3 protein was expressed regularly (P > 0.05) in different presentations of CC, but significant lower frequency of positivity was found in the ductular histological subtype (P=0.023). In conclusion, the excellent signal-to-noise ratio, reasonably high frequency of HCC positivity and full negativity of CC to BSEP lead us to recommend the introduction of the anti-BSEP monoclonal antibody in the panel adopted for the differential diagnosis of these two neoplasms. The high expression of MRP2 in HCC and in CC is conserved independently of the pathological parameters evaluated herein. The frequency of expression of the MRP3 transporter varied among the histological subtypes of CC, which makes promising future research for a more detailed assessment of the expression of this marker in the cholangiocarcinomas

Giardia duodenalis est le protozoaire responsable de la giardiose, la parasitose intestinale la plus répandue dans le monde. Cette infection se caractérise par une malabsorption intestinale, des diarrhées, une perte de poids et des douleurs abdominales intenses chez l’Homme et de nombreux mammifères. Par ailleurs, cette maladie dont l’impact en santé publique et vétérinaire est reconnu, peut entraîner d’importantes déficiences nutritionnelles en particulier chez les sujets jeunes. L’infection est causée par l’ingestion de kystes de Giardia duodenalis (syn. G. lamblia, G. intestinalis) présents dans les aliments ou l’eau contaminée. Infectieux à très faibles doses, ces kystes survivent pendant plusieurs semaines dans l’environnement et sont résistants aux différents désinfectants. Suite au dékystement, la forme végétative de Giardia, le trophozoïte, adhère à l’épithélium intestinal au niveau des parties supérieures de l’intestin grêle et se multiplie, causant les symptômes. Cette phase se termine par un nouvel enkystement et l’excrétion de kystes par les fèces. Le nombre croissant d’infections liées à la contamination de l’eau potable, à l’émergence de souches résistantes aux médicaments disponibles, à la fréquence des échecs thérapeutiques et à l’importance des effets secondaires associés aux traitements font de cette maladie un sujet d’actualité de plus en plus préoccupant qui nécessite le développement de traitements alternatifs. Il est désormais bien établi que le microbiote et/ou certaines souches de bactéries probiotiques ont un impact bénéfique dans la giardiose. En particulier, la bactérie probiotique Lactobacillus johnsonii La1 (LjLa1) a un rôle protecteur contre la croissance de Giardia in vitro et in vivo. Nous avons cherché dans ce travail de Thèse à décrypter les mécanismes moléculaires associés à l’effet inhibiteur des facteurs sécrétés par LjLa1. Nous avons montré qu’in vitro, LjLa1 agissait en libérant des enzymes de type Bile Salt Hydrolases (BSH) qui modifient alors des composants de la bile non-toxiques pour le parasite (sels biliaires conjugués) en des composants toxiques (sels biliaires déconjugués). Les 3 gènes BSH codés dans le génome de LjLa1 ont été clonés chez Escherichia coli et les protéines taguées histidine purifiées pour étudier leurs propriétés biochimiques et biologiques. Obtenues sous forme active, nous avons pu en définir les spécificités de substrats et montrer qu’elles sont capables d’inhiber significativement la croissance de G. duodenalis in vitro et in vivo, dans un modèle murin de la giardiose (souriceaux OF1 non sevrés). En parallèle, nous avons identifié, à l’issue d’un large criblage de souches de lactobacilles selon leur activité anti-Giardia in vitro, une souche probiotique aux effets inhibiteurs comparables à ceux de LjLa1 : Lactobacillus gasseri CNCM-4884. Administrée in vivo dans le modèle murin de la giardiose, cette souche a réduit de 93% la charge parasitaire dans l'intestin grêle des nouveaux nés et a également réduit de façon significative le nombre de kystes libérés dans l’environnement, permettant ainsi de réduire la transmission de Giardia. Des travaux parallèles ont été réalisés au cours de ce projet de Thèse, notamment le développement d’outils de moléculaire pour l’expression hétérologue de molécules d’intérêt en santé animale chez divers lactobacilles. Le développement de ces « vecteurs mucosaux » permettra à terme de proposer une stratégie de surexpression de BSH par les lactobacilles afin d’accroitre l’activité BSH in vivo, et renforcer ainsi l’élimination du parasite. Ces résultats permettent de proposer de nouvelles pistes thérapeutiques originales contre les giardioses humaines et animales, basées sur l’utilisation de lactobacilles probiotiques ou sur les activités BSH qui en sont dérivées. Ces traitements offrent alors une alternative sérieuse aux antibiotiques et permettront de pallier aux actuels fréquents échecs thérapeutiques. / Giardia duodenalis is a protozoan parasite responsible for giardiasis, the most common intestinal parasitic disease worldwide. This infection is characterized by intestinal malabsorption, diarrhea, weight loss and abdominal pain in humans and various mammalian species. Besides, this disease has a high veterinary and public health impact, leading to important nutritional deficiencies in young subjects. The infection is caused by the ingestion of food or water contaminated with infectious cysts of the parasite. Giardia cysts can survive for several weeks in the environment and are highly resistant to disinfectants. Giardia excysts in the intestinal tracts of its host and replicates under the trophozoite stage causing the symptoms. Trophozoites adhere to the intestinal epithelium of the small intestine and multiply, causing the symptoms. The cycle ends by a new encystment and infectious cysts are released in environments with feces. The increasing number of giardiasis cases, mainly due to water contaminations, the emergence of parasite strains resistant to drugs and therapeutic failures, make research on alternative therapeutic strategies and treatments highly needed. Nowadays, it is well known that the microbiota and probiotics play an important role in protection against this parasite. For instance, the probiotic strain Lactobacillus johnsonii La1 (LjLa1) prevents the establishment of Giardia in vitro and in vivo. In this thesis, we have tried to point out the molecular mechanism(s) involved in this inhibitory effect(s). We showed in vitro that LjLa1 was releasing "Bile Salt Hydrolases" (BSH) – like activities that modify some components of bile (conjugated bile salts) into toxic compounds (deconjugated bile salts) for Giardia. We have cloned and expressed each of the three bsh genes present in the genome of LjLa1 in Escherichia coli in order to study their enzymatic and biological properties. Two BSH were obtained as recombinant active enzymes and biochemical tests showed that they have distinct substrate specificities despite similar predicted 3D structures. Moreover, these two BSHs of LjLa1 exhibited anti-giardial effects in vitro and in vivo in a murine model of the giardiasis (OF1suckling mice), comforting the hypothesis of the biological role of active BSH, derived from probiotics, against Giardia. A wide collection of diverse lactobacilli strains was screened to assess their effectiveness to also display both anti-giardial and BSH activities. This screening allowed the identification of several strains exhibiting strong anti-giardial effects such as Lactobacillus gasseri CNCM I-4884. In a murine model of giardiasis, this strain dramatically reduced the parasite burden in the small intestine of treated animals and significantly reduced the number of cysts in the colon, which could contribute to blockage of parasite transmission in environments. Additional studies were realized in parallel in order to explore the potency of lactobacilli to exert beneficial effects on health. For this, molecular tools were successfully developed in various lactobacilli strains to express and deliver therapeutic molecules at mucosal surfaces. The development of these tools will further allow the overexpression of BSH by lactobacilli to increase their in vivo BSH-activity and strengthen the elimination of the parasite. Altogether, this thesis work proposes new original therapeutic strategies against human and animal giardiasis, based on the use of BSH-positive lactobacilli strains or recombinant BSH- derived from probiotic strains, to counteract the frequent therapeutic failures, offering a serious alternative to antibiotics.

Bibliography: leaves 171-211 / 211 leaves : / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (M.D.)--University of Adelaide, 1988

Diss. (sammanfattning) Stockholm : Karol. inst., 2003. / Härtill 4 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2004. / Härtill 5 uppsatser.

A lama biliar em cães é considerada um achado incidental, sendo frequentemente identificada durante ultrassonografias abdominais como sedimento ecogênico de baixa amplitude sem sombra acústica e com mobilidade gravidade dependente. Em humanos, a presença de lama biliar é considerada anormal e está associada a diversas situações clínicas e complicações como cálculos biliares, colangite e pancreatite aguda. Em cães sua importância clínica ainda é desconhecida. Os objetivos deste estudo foram estimar a prevalência, avaliar fatores de risco, alterações encontradas ao exame de ultrassom e marcadores bioquímicos em cães com lama biliar diagnosticada por ultrassonografia. Determinou-se a prevalência e a influência das diferentes raças, sexo e idade na lama biliar, a partir de 1.021 cães submetidos à ultrassonografia abdominal, independente do estado de saúde. Desse total, foram selecionados por conveniência, 100 cães para avaliação das alterações encontradas na ultrassonografia, dos fatores de risco e dos marcadores bioquímicos perante a presença ou ausência de lama biliar. Os resultados mostraram que a prevalência de lama biliar é alta, sendo que cães com 10 anos ou mais estiveram mais predispostos. Machos e fêmeas foram acometidos em igual intensidade, havendo uma maior prevalência nas raças Beagle, Cocker Spaniel e Poodle. Nenhum dos marcadores bioquímicos estudados demonstrou correlação significativa com a lama e através da quantificação desse sedimento foi possível sugerir que o espessamento biliar raramente progride podendo acarretar complicações mais graves como a mucocele e colelitíase. Condição corporal e a castração não demonstraram relação com a presença de lama biliar e o tipo de dieta não foi considerado como o principal fator de risco, havendo apenas fraca associação da lama com o abuso da alimentação com petiscos veterinários. Já o uso de medicamentos demonstrou estar entre as possíveis causas para o desenvolvimento do espessamento biliar. Pacientes com doenças cardiovasculares encotraram-se no grupo de risco e a maior ocorrência de hepatomegalia nos cães acometidos pela lama foi associada à congestão hepática passiva, consequência das cardiopatias. Acredita-se que o fator idade também possa estar relacionado a esse fato, já que as cardiopatias são mais frequentes em cães mais velhos. / The biliary sludge in dogs is deemed to be an incidental finding, and is often identified during abdominal ultrasound as echogenic sediment of low amplitude without acoustic shadowing and gravity dependent mobility. In humans, the presence of biliary sludge is considered abnormal and it is associated with various medical conditions and complications such as gallstones, cholangitis and acute pancreatitis. In dogs their clinical importance is still unknown. The aims of this study were to estimate prevalence, evaluate risk factors, findings on ultrasound examination and biochemical markers in dogs with biliary sludge diagnosed by ultrasonography. It was determined the prevalence and influence of different breeds, gender and age in biliary sludge, from 1.021 dogs undergoing abdominal ultrasonography, regardless of their health status. Overall, it was selected for convenience, 100 dogs for evaluation of abnormalities found on ultrasound, the risk factors and biochemical markers before the presence or absence of biliary sludge. The results showed that the prevalence of biliary sludge is high, and dogs with 10 years old or more were more predisposed. Males and females were affected at the same intensity, with greater prevalence in breeds Beagle, Cocker Spaniel and Poodle. None of the biochemical markers studied showed a significant correlation with the sludge and through the quantification of sediment was possible to suggest that the thickened bile rarely progresses and may cause more serious complications such as mucocele and cholelithiasis. Body condition and castration showed no correlation with the presence of biliary sludge and the type of diet was not considered a major risk factor, with only a weak association of the sludge with the abuse with veterinarians’ snacks. But the use of medicines proved to be among the possible causes for the development of the thickened bile. Patients with cardiovascular diseases lay in the risk group and higher incidence of hepatomegaly in dogs affected by the mud was associated to passive hepatic congestion, as consequence of cardiopathies. It is believed that the age factor may also be related to this fact, since cardiopathies are more common in older dogs.

A lama biliar em cães é considerada um achado incidental, sendo frequentemente identificada durante ultrassonografias abdominais como sedimento ecogênico de baixa amplitude sem sombra acústica e com mobilidade gravidade dependente. Em humanos, a presença de lama biliar é considerada anormal e está associada a diversas situações clínicas e complicações como cálculos biliares, colangite e pancreatite aguda. Em cães sua importância clínica ainda é desconhecida. Os objetivos deste estudo foram estimar a prevalência, avaliar fatores de risco, alterações encontradas ao exame de ultrassom e marcadores bioquímicos em cães com lama biliar diagnosticada por ultrassonografia. Determinou-se a prevalência e a influência das diferentes raças, sexo e idade na lama biliar, a partir de 1.021 cães submetidos à ultrassonografia abdominal, independente do estado de saúde. Desse total, foram selecionados por conveniência, 100 cães para avaliação das alterações encontradas na ultrassonografia, dos fatores de risco e dos marcadores bioquímicos perante a presença ou ausência de lama biliar. Os resultados mostraram que a prevalência de lama biliar é alta, sendo que cães com 10 anos ou mais estiveram mais predispostos. Machos e fêmeas foram acometidos em igual intensidade, havendo uma maior prevalência nas raças Beagle, Cocker Spaniel e Poodle. Nenhum dos marcadores bioquímicos estudados demonstrou correlação significativa com a lama e através da quantificação desse sedimento foi possível sugerir que o espessamento biliar raramente progride podendo acarretar complicações mais graves como a mucocele e colelitíase. Condição corporal e a castração não demonstraram relação com a presença de lama biliar e o tipo de dieta não foi considerado como o principal fator de risco, havendo apenas fraca associação da lama com o abuso da alimentação com petiscos veterinários. Já o uso de medicamentos demonstrou estar entre as possíveis causas para o desenvolvimento do espessamento biliar. Pacientes com doenças cardiovasculares encotraram-se no grupo de risco e a maior ocorrência de hepatomegalia nos cães acometidos pela lama foi associada à congestão hepática passiva, consequência das cardiopatias. Acredita-se que o fator idade também possa estar relacionado a esse fato, já que as cardiopatias são mais frequentes em cães mais velhos. / The biliary sludge in dogs is deemed to be an incidental finding, and is often identified during abdominal ultrasound as echogenic sediment of low amplitude without acoustic shadowing and gravity dependent mobility. In humans, the presence of biliary sludge is considered abnormal and it is associated with various medical conditions and complications such as gallstones, cholangitis and acute pancreatitis. In dogs their clinical importance is still unknown. The aims of this study were to estimate prevalence, evaluate risk factors, findings on ultrasound examination and biochemical markers in dogs with biliary sludge diagnosed by ultrasonography. It was determined the prevalence and influence of different breeds, gender and age in biliary sludge, from 1.021 dogs undergoing abdominal ultrasonography, regardless of their health status. Overall, it was selected for convenience, 100 dogs for evaluation of abnormalities found on ultrasound, the risk factors and biochemical markers before the presence or absence of biliary sludge. The results showed that the prevalence of biliary sludge is high, and dogs with 10 years old or more were more predisposed. Males and females were affected at the same intensity, with greater prevalence in breeds Beagle, Cocker Spaniel and Poodle. None of the biochemical markers studied showed a significant correlation with the sludge and through the quantification of sediment was possible to suggest that the thickened bile rarely progresses and may cause more serious complications such as mucocele and cholelithiasis. Body condition and castration showed no correlation with the presence of biliary sludge and the type of diet was not considered a major risk factor, with only a weak association of the sludge with the abuse with veterinarians’ snacks. But the use of medicines proved to be among the possible causes for the development of the thickened bile. Patients with cardiovascular diseases lay in the risk group and higher incidence of hepatomegaly in dogs affected by the mud was associated to passive hepatic congestion, as consequence of cardiopathies. It is believed that the age factor may also be related to this fact, since cardiopathies are more common in older dogs.